{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/669fdc0e993be95c7f810414/6a3914564a8189f2c3b80c63?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Programming Biology: How Basecamp Research is using AI to transform medicine – Part 2 ","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/669fdc0e993be95c7f810414/1782125690485-21a78fd4-75a4-4422-bea9-10aa87d2d0b6.jpeg?height=200","description":"<p>The conversation continues: in part two of our discussion with Basecamp Research co-founders Glen Gowers and Oliver Vince, we explore what the future of AI-powered medicine could look like, how the company is working with partners including NVIDIA and Anthropic, and why they believe biology can become programmable.&nbsp;</p><p><br></p><p>The founders discuss personalised healthcare, the role of large-scale biological datasets, the challenge of communicating ambitious scientific ideas, and the leadership lessons they've learned while building one of the UK's most exciting AI companies.&nbsp;</p><p><br></p><p>If you haven't already, be sure to listen to part one where Glen and Oliver share the origin story behind Basecamp Research and the expedition that inspired its mission.</p>","author_name":"Brands2Life"}